AMLX
AmylyxCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
AMLX vs peer average
49/100
AMLX vs. peer average (C vs. C)
Grade spread
B 5 · C 2 · D 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
ANAB is the first available peer comparator.
AnaptysBio is a closer small-cap clinical-stage biotech valuation analog than a commercial pharma comp, with equity value largely driven by pipeline milestone timing rather than current earnings power; the comparison is useful for event-risk framing but not a direct indication match.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
AMLX
Amylyx
ANAB
AnaptysBio
Grade
C
B
Momentum
81
83
Value
41
41
Sentiment
39
51
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Constructive
Grade position vs ANAB
AMLX / ANAB
Grade Position
In line
AMLX vs. peer average (C vs. C)
49/100
Momentum
81
ANABValue
41
AMLXSentiment
39
ANABRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs AMLX
ANAB is the first peer returned for this comparison set.